Drug Detail:Human albumin grifols (human) (Albumin (human) [ al-bue-min ])
Generic Name: Albumin Human 10g in 50mL
Dosage Form: injection, solution
Drug Class: Plasma expanders
Drug Detail:Human albumin grifols (human) (Albumin (human) [ al-bue-min ])
Generic Name: Albumin Human 10g in 50mL
Dosage Form: injection, solution
Drug Class: Plasma expanders
For Intravenous Use Only
Adjust the concentration, dosage and infusion rate of the albumin preparation to the patient's individual requirements.
The dose required depends on the patient's body weight, severity of injury/illness and on continuing fluid and protein losses. Use adequacy of circulating blood volume, not plasma albumin levels, to determine the dose required.
Indication | Dose |
Hypovolemia | Adults: Initial dose of 20 g. If hemodynamic stability is not achieved within 15 to 30 minutes, an additional dose may be given. Hemodilution may follow administration of Human Albumin Grifols 20%. Anemia resulting from hemorrhage should be corrected by administration of compatible red blood cells or compatible whole blood. For acute liver failure: initial dose of 12 to 25 g. An infusion rate of 1-2 mL per min is usually indicated. For renal dialysis, the initial dose should not exceed 20 g and patients should be carefully observed for signs of fluid overload. |
Cardiopulmonary bypass procedures | Adults: Initial dose of 25 g. Additional amounts may be administered as clinically indicated. |
Acute nephrosis | Adults: 25 g together with diuretic once a day for 7 - 10 days. |
Hypoalbuminemia | Adults: 50 to 75 g. For pre- and post-operative hypoproteinemia: 50 to 75 g. In burns, therapy usually starts with administration of large volumes of crystalloid solution to maintain plasma volume. After 24 hours: initial dose of 25 g and dose adjustment to maintain plasma protein concentration of 2.5 g per 100 mL or a serum protein concentration of 5.2 g per 100 mL. Third space protein loss due to infection: initial dose of 50 to 100 g. An infusion rate of 1-2 mL per minute is usually indicated in the absence of shock. Treatment should always be guided by hemodynamic response. |
Ovarian hyperstimulation syndrome | Adults: 50 g to 100 g over 4 hours and repeated at 4-12 hour intervals as necessary, when infusion of normal saline fails to achieve or maintain hemodynamic stability and urine output. |
Neonatal hyperbilirubinemia | 1 g per kilogram body weight prior to or during exchange transfusion. |
Adult respiratory distress syndrome (ARDS) | Adults: 25 g over 30 minutes and repeated at 8 hours for 3 days, if necessary. |
Prevention of central volume depletion after paracentesis due to cirrhotic ascites | Adults: 8 g for every 1000 mL of ascitic fluid removed. |
Intravenous use only